21 February 2023>: Articles
Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report
Unknown etiology, Adverse events of drug therapy
Jayson P. Jessop A , Joshua Russell A , Adriana DeJesus A , Chandni Bardolia A , Abeer Hanna B , Jacques Turgeon A* , Veronique Michaud A , Nishita S. Amin ADOI: 10.12659/AJCR.938850
Am J Case Rep 2023; 24:e938850
Table 1. Medications at time of enrollment.
Indication | Medication | Dose | Frequency |
---|---|---|---|
Prevention of atherosclerotic cardiovascular disease | Atorvastatin | 20 mg | Once daily |
Ezetimibe | 10 mg | Once daily | |
HTN, heart disease | Carvedilol | 12.5 mg | Twice daily |
Furosemide | 20 mg | Once daily | |
HTN, atrial fibrillation | Diltiazem | 120 mg | Twice daily |
Endocarditis prophylaxis | Doxycycline hyclate | 100 mg | Twice daily |
MDD | Fluoxetine | 20 mg | Once daily |
Type II diabetes | Dulaglutide (subcutaneous) | 0.75 mg | Once weekly |
Insulin glargine (subcutaneous) | 10 units | Three times daily | |
Insulin aspart (subcutaneous) | 5 units | Once daily | |
GERD | Lansoprazole | 30 mg | Once daily |
Hypothyroidism | Levothyroxine | 200 mcg | Once daily |
Anxiety | Lorazepam | 0.5 mg | Up to 3 times daily |
Atrial fibrillation | Warfarin | 17.5 mg | Weekly |
GERD – gastroesophageal reflux disease; HTN – hypertension; MDD – major depressive disorder. |